University of Oxford
Trending Articles
Related Content
Research & Development
Alternating vaccines trial expands to include two additional vaccines
Volunteers, who will have received either the Oxford-AstraZeneca, or Pfizer vaccine, will be randomly allocated to receive either the same vaccine for their second dose, or a dose of the COVID-19 vaccines produced by Moderna or Novavax